Prospective observational study on the complications and tolerability of a peripherally inserted central catheter (PICC) in neuro-oncological patients

  • G. SimonettiEmail author
  • A. Sommariva
  • M. Lusignani
  • E. Anghileri
  • C. Basso Ricci
  • M. Eoli
  • A. V. Fittipaldo
  • P. Gaviani
  • C. Moreschi
  • S. Togni
  • I. Tramacere
  • A. Silvani
Original Article



The use of central venous catheters with peripheral insertion (PICC) has increased rapidly in recent years, particularly in cancer patients. The benefits provided may occasionally be affected by relevant complications, such as infections and thrombotic events, especially in neuro-oncological patients. To date, the risk of PICC-related complications in this subset of patients is unknown, as is tolerability. As a primary objective, this study aimed to collect complications related to PICCs in primary neuro-oncological patients. As a secondary objective, the study aimed to evaluate PICC tolerability.


Neuro-oncological patients with PICCs that were placed as part of normal clinical practice at IRCCS Neurologico C. Besta were consecutively enrolled in the study. PICC-related complications were recorded immediately (during the procedure), early (within 1 week after PICC insertion), and late (1–3-5 months after PICC placement). At the same time points, all patients were also evaluated for tolerability through interviews with semi-structured, open-ended questions.


Sixty patients were enrolled (41 males and 19 females, with a median age of 56.2 years). Excluding loss to follow-up, 33/49 patients developed at least one complication related to the PICC. Immediate complications mainly included hematoma (8), accidental arterial puncture (4), and primary malpositioning (3). Regarding early and late complications, 3 device-related infections, 8 thrombotic events, and 20 mechanical complications were registered. Semi-structured interviews revealed an overall positive experience with the device. The most negative impact was on hygiene habits, with 34 patients becoming caregiver-dependent. Over time, almost all patients became used to the device and perceived greater security during chemotherapy. A strongly negative issue was the difficulty of relying on competently trained healthcare personnel in outpatient setting.


The results showed a nonnegligible increased thromboembolic risk in neuro-oncological patients with PICCs, almost double that in historical oncological populations. It is essential to extend the study to a greater number of patients to achieve reliable results and to identify patients at high risk. The device seems to be positively accepted by the majority of patients, without affecting activities of daily living.


Peripherally inserted central catheter (PICC) High-grade glioma Catheter-related bloodstream infection (CRBSI) Catheter-related thromboembolism 


Compliance with ethical standards

All human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All participants gave their informed consent prior to their inclusion in the study.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Sousa B, Furlanetto J, Hutka M et al (2015) Central venous access in oncology: ESMO clinical practice guidelines. Ann Oncol 26(Suppl 5):v152–v168CrossRefGoogle Scholar
  2. 2.
    Cotogni P, Pittiruti M (2014) Focus on peripherally inserted central catheters in critically ill patients. World J Crit Care Med 3(4):80–94CrossRefGoogle Scholar
  3. 3.
    O'Grady NP, Alexander M, Burns LA (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52(9):e162–e193CrossRefGoogle Scholar
  4. 4.
    Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, Iorio A, Brambilla G (1998) Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339:80–85CrossRefGoogle Scholar
  5. 5.
    Constantini S, Kanner A, Friedman A, Shoshan Y, Israel Z, Ashkenazi E, Gertel M, Even A, Shevach Y, Shalit M, Umansky F, Rappaport ZH (2001) Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study. J Neurosurg 94:918–921CrossRefGoogle Scholar
  6. 6.
    Macdonald RL, Amidei C, Baron J et al (2003) Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol 59:363–372CrossRefGoogle Scholar
  7. 7.
    Perry JR (2012) Thromboembolic disease in patients with high-grade glioma. Neuro-Oncology 14(Suppl 4):iv73–iv80CrossRefGoogle Scholar
  8. 8.
    Hohaus S, Tisi MC, Bartolomei F et al (2018) Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization. Blood Cancer J 8(6):54CrossRefGoogle Scholar
  9. 9.
    Mahajan A, Brunson AM, Keegan THM et al (2017) Incidence of venous thromboembolism and impact on mortality in patients with primary CNS lymphoma: a population based study. Blood 130:754Google Scholar
  10. 10.
    Chopra V, O'Horo JC, Rogers MA (2013) The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 34(9):908–918CrossRefGoogle Scholar
  11. 11.
    Kramer RD, Rogers MA, Conte M (2017) Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis. Am J Infect Control 45(2):108–114CrossRefGoogle Scholar
  12. 12.
    Cameron AC, Touyz RM, Lang NN (2016) Vascular complications of cancer chemotherapy. Can J Cardiol 32(7):852–862CrossRefGoogle Scholar
  13. 13.
    Cotogni P, Barbero C, Garrino C (2015) Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. Support Care Cancer 23(2):403–409CrossRefGoogle Scholar
  14. 14.
    Tian G, Zhu Y, Qi L, Guo F, Xu H (2010) Efficacy of multifaceted interventions in reducing complications of peripherally inserted central catheter in adult oncology patients. Support Care Cancer 18:1293–1298CrossRefGoogle Scholar
  15. 15.
    Marmel LA (2000) Prevention of intravascular catheter-related infections. Ann Intern Med 132:391–402CrossRefGoogle Scholar
  16. 16.
    Kang J, Chen W, Sun W, Ge R, Li H, Ma E, Su Q, Cheng F, Hong J, Zhang Y, Lei C, Wang X, Jin A, Liu W (2017) Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days. J Vasc Access 18(2):153–157CrossRefGoogle Scholar
  17. 17.
    Lin RJ, Green DL, Shah GL (2018) Therapeutic anticoagulation in patients with primary brain tumors or secondary brain metastasis. Oncologist 23(4):468–473CrossRefGoogle Scholar
  18. 18.
    King MM, Rasnake MS, Rodriguez RG, Riley NJ, Stamm JA (2006) Peripherally inserted central venous catheter–associated thrombosis: retrospective analysis of clinical risk factors in adult patients. South Med J 99(10):1073–1077CrossRefGoogle Scholar
  19. 19.
    Marnejon T, Angelo D, Abu Abdou A, Gemmel D (2012) Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters. J Vasc Access 13(2):231–238CrossRefGoogle Scholar
  20. 20.
    Kahale LA, Tsolakian IG, Hakoum MB et al (2018) Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev (6)Google Scholar
  21. 21.
    Park K, Jun HJ, Oh SY (2016) Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study. Support Care Cancer 24(12):4987–4992CrossRefGoogle Scholar
  22. 22.
    Parás-Bravo P, Paz-Zulueta M, Santibañez M (2018) Living with a peripherally inserted central catheter: the perspective of cancer outpatients-a qualitative study. Support Care Cancer 26(2):441–449CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • G. Simonetti
    • 1
    Email author
  • A. Sommariva
    • 2
  • M. Lusignani
    • 3
  • E. Anghileri
    • 4
  • C. Basso Ricci
    • 5
  • M. Eoli
    • 4
  • A. V. Fittipaldo
    • 6
  • P. Gaviani
    • 1
  • C. Moreschi
    • 7
  • S. Togni
    • 8
  • I. Tramacere
    • 6
  • A. Silvani
    • 1
  1. 1.Neuro-oncology Unit, Department of Clinical NeurosciencesFondazione IRCCS Istituto Neurologico Carlo BestaMilanItaly
  2. 2.Department of Neuro-anesthesiaFondazione IRCCS Istituto Neurologico Carlo BestaMilanItaly
  3. 3.Department of Biomedical Sciences for HealthUniversity of MilanMilanItaly
  4. 4.Neurology VIII-Molecular Neuro-Oncology UnitFondazione IRCCS Istituto Neurologico Carlo BestaMilanItaly
  5. 5.Neuroradiology UnitFondazione IRCCS Istituto Neurologico Carlo BestaMilanItaly
  6. 6.Department of Research and Clinical Development, Scientific DirectorateFondazione IRCCS Istituto Neurologico Carlo BestaMilanItaly
  7. 7.S.I.T.R.AFondazione IRCCS Neurologico Carlo BestaMilanItaly
  8. 8.S.I.T.R.AFondazione IRCCS Istituto Nazionale dei TumoriMilanItaly

Personalised recommendations